Taipei Exchange - Delayed Quote TWD

TTY Biopharm Company Limited (4105.TWO)

75.20
-0.40
(-0.53%)
At close: May 28 at 1:30:01 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in TWD.
NameTitlePayExercisedYear Born
Mr. Kuo-Chiang Chang Chief Financial Officer -- -- --
Ms. Shu-Wen Wang Accounting Officer -- -- --
Ms. Shu-Fen Huang Chief Legal & Compliance Officer -- -- --
Wei-Ying Yin Director of Public Affairs Department -- -- --
Mr. Jen-Yang Chang Chief Human Resource Officer -- -- --
Ms. Si-Yuan Yang Senior Vice President -- -- --
Mr. Allen Chu Head of Intensive Care Business Unit -- -- --
Ms. Ching-Lan Hou General Manager -- -- --
Yung-Min Chiang Chief Auditor -- -- --

TTY Biopharm Company Limited

No.3-1, Park Street
3rd Floor Nangang District
Taipei, 11503
Taiwan
886 2 2652 5999 https://www.tty.com.tw
Sector: 
Healthcare

Description

TTY Biopharm Company Limited, together with its subsidiaries, engages in the development and sale of pharmaceutical and chemical drugs in Taiwan and internationally. The company operates through Oncology Business Unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business Unit, and Other Business Unit segments. It offers oncology drugs under the Lipo-Dox, Lonsurf, UFUR, TS-1, Pexeda, Gemmis, Oxalip, Irino, Epicin, Tynen, Anazo, Folina, Thado, Andason, Ivic, Asadin, Leavdo, Painkyl, Megest, Episil, Otril, Zobonic, Yondelis, and Pemazyre names for anti-cancer and supplementary treatments. The company provides anti-infection drugs under the Brosym, Colimycin, Cubicin, Lipo-AB, Agrippal, Cepiro, Flusine, Maxtam, Metacin, and Flucelvax names for anti-infection and flu. In addition, it offers healthcare related drugs under the Algitab, Alginos, Alginos Fresh, Bio-Cal Plus, and Sulfin names for digest system, osteoporosis, and metabolism. Further, the company engages in the selling functional foods; and import and export trading and investment activities. The company was incorporated in 1960 and is headquartered in Taipei, Taiwan.

Corporate Governance

TTY Biopharm Company Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 6, 2025 at 10:59 AM UTC - August 11, 2025 at 12:00 PM UTC

TTY Biopharm Company Limited Earnings Date

Recent Events

March 27, 2025 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers